Arimoclomol Terminated Phase 2 Trials for Gaucher Disease, Type 1 / Gaucher Disease, Type III Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03746587Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3